For citations:
Nasonov E.L., Korotaeva T.V., Rodolfi S., Selmi C.F. Prospects for the use of monoclonal antibodies to interleukin 23 Gusеlkumab in psoriatic arthritis: New data. Rheumatology Science and Practice. 2022;60(1):80–90. https://doi.org/10.47360/1995-4484-2022-80-90
Email this article 